Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 DAC Dosage, Reconstitution & Mixing Trends | World Peptide Association

Explore CJC-1295 DAC dosage trends, reconstitution volumes, and vial size patterns from WPA peptide calculator sessions.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

CJC-1295 DAC Dosage, Reconstitution & Mixing Trends

Explore CJC-1295 DAC dosage trends, reconstitution volumes, and vial size patterns from WPA peptide calculator sessions.

CJC-1295 DAC is a long-acting GHRH analog modified with a drug affinity complex (DAC) that extends its half-life to several days, allowing for less frequent injections than the non-DAC form. This data shows the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when reconstituting CJC-1295 DAC.

242 CJC-1295 DAC reconstitution calculations have been logged by the WPA community. The most common dose entered is 2mg (61 calculations). The median dose across all sessions is 1mg. The most common bacteriostatic water volume is 2mL. The most popular vial size is 5mg (158 sessions). The most common dosing frequency is once weekly (31 logged protocols), followed by 2x/week (6).

World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community.

All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.

Connected topics

Follow this recovery question